Publications by authors named "Helene Maillard"

Claim this Profile
F
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study.
Anne Murarasu, Lauren Beaudeau, Veronique Le Guern, Gaelle Guettrot-Imbert, Claire Cazalets, Helene Maillard

Lancet Rheumatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.
Clémence David, Nadia Nathan, Eslam Al-Abadi, Peter D Arkwright, Brigitte Bader-Meunier, Hélène Maillard

Ann Rheum Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.
Sophie Dupuis-Girod, Evelyne Decullier, Sophie Rivière, Christian Lavigne, Vincent Grobost, Hélène Maillard

Ther Adv Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Robin Bouillé, Soumaya Balbolia, Audrey Barbet, Caroline Barry, Émilie Cappelle, Hélène Maillard

Sante Publique· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass cytometry reveals atypical immune profile notably impaired maturation of memory CD4 T with Gb3-related CD27 expression in CD4 T cells in Fabry disease.
Wladimir Mauhin, Gaelle Dzangue-Tchoupou, Damien Amelin, Aurélien Corneau, Foudil Lamari, Hélène Maillard

J Inherit Metab Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programme.
Pascale Antoine, Sandrine Morell-Dubois, Hélène Maillard, Geraldine Wojtasik, Sebastien Sanges

Clin Exp Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Sophie Dupuis-Girod, Sophie Rivière, Christian Lavigne, Anne-Emmanuelle Fargeton, Brigitte Gilbert-Dussardier, Hélène Maillard

J Intern Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with pathogenic variants.
Alexandre Guilhem, Sophie Dupuis-Girod, Olivier Espitia, Sophie Rivière, Julie Seguier, Hélène Maillard

J Med Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL).
Vincent Grobost, Sami Hammi, Bruno Pereira, Alexandre Guilhem, Pierre Duffau, Hélène Maillard

Thromb Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.
Yann Nguyen, Cécile M Yelnik, Nathalie Morel, Romain Paule, Romain Stammler, Hélène Maillard

Rheumatology (Oxford)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?
Quentin Ducrocq, Laurence Guédon-Moreau, David Launay, Louis Terriou, Sandrine Morell-Dubois, Hélène Maillard

Healthcare (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.
Anastasia Dupré, Nathalie Morel, Cécile Yelnik, Philippe Moguelet, Véronique Le Guern, Hélène Maillard

JAMA Dermatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients.
Cécile M Yelnik, Claire Martin, Emmanuel Ledoult, Sébastien Sanges, Vincent Sobanski, Hélène Maillard

Lupus· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The transitional care from pediatrics to adult medicine within the rare autoimmune and autoinflammatory diseases network].
Muriel Herasse, Mélanie Romier, Véronique Hentgen, Agnès Duquesne, Jean-Paul Larbre, Hélène Maillard

Med Sci (Paris)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis.
Liticia Chikhoune, Thierry Brousseau, Sandrine Morell-Dubois, Meryem Maud Farhat, Helene Maillard

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT.
Thi Thao Truc Le, Guillaume Martinent, Sophie Dupuis-Girod, Antoine Parrot, Anne Contis, Hélène Maillard

Orphanet J Rare Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY.
Antoine Asquier-Khati, Wladimir Mauhin, Guillaume Michel, Adrien Gendre, Cécile Durant, Hélène Maillard

Eur Arch Otorhinolaryngol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease.
Wladimir Mauhin, Abdellah Tebani, Damien Amelin, Lenaig Abily-Donval, Foudil Lamari, Hélène Maillard

J Clin Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical management of patients on hydroxychloroquine.
Christophe Richez, Nadège Cordel, Hélène Maillard, Alexandra Willems, François Chasset

Joint Bone Spine· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).
Benjamin Terrier, Raphaël Darbon, Cécile-Audrey Durel, Eric Hachulla, Alexandre Karras, Hélène Maillard

Orphanet J Rare Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
Amélie Leurs, Sylvain Dubucquoi, François Machuron, Maïté Balden, Florence Renaud, Hélène Maillard

Joint Bone Spine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study.
David Saadoun, Amine Ghembaza, Sebastien Riviere, Arsene Mekinian, Jonathan Boutemy, Helene Maillard

J Autoimmun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).
Benjamin Terrier, Raphaël Darbon, Cécile-Audrey Durel, Eric Hachulla, Alexandre Karras, Hélène Maillard

Orphanet J Rare Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study.
Philippe Mertz, Jean-François Kleinmann, Marc Lambert, Xavier Puéchal, Anthony Bonnin, Helene Maillard

Autoimmun Rev· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy.
Nicolas Junqua, Damien Legallois, Sophie Segard, Olivier Lairez, Patricia Réant, Hélène Maillard

Arch Cardiovasc Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis